About Us

Founded in 2013 by a group of passionate synthetic biologists with decades of industry experience and a proven track record of delivering cost-effective DNA solutions, Synbio Technologies is incorporated with a single mission in mind: to empower scientific discoveries and drug innovation by providing the most advanced and cost-effective DNA technology platform. The company has developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities and delivered satisfactory solutions to global researchers for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, and biofuel implication etc.

The company’s scientific capabilities cover all facets of DNA synthesis and engineering and offers a full range of supporting molecular biology work, including but not limited to:

  • Oligo synthesis
  • Gene synthesis
  • Subcloning & PCR cloning
  • Plasmid preparation (up to gram scale)
  • Mutagenesis
  • DNA variants libraries (Permutation, random, trimer libraries, etc)
  • CRISPR sgRNA
  • Protein expression and purification in multiple systems (E.coli, yeast and mammalian cells)

Furthermore, relying on our strong DNA sequencing, synthesis and engineering technology platform, and expertise in bioinformatics analysis, Synbio Tech has developed proprietary algorithms to facilitate and expedite the antibody discovery process. Our antibody discovery services include:

  • Hybridoma sequencing
  • Immune repertoire sequencing
  • Antibody design and production
  • AI-guided heavy chain and light chain pairing

  • Antibody humanization
  • Affinity maturation
  • sdAb (Single Domain Antibody)

The company has over 250 scientific staff and its state of the art production facility is certified with the highest DNA manufacturing standards (ISO9001 & ISO13485).